Suppr超能文献

用于体外静态时间杀灭研究中量化细菌杀灭和再生长的新型速率-面积-形状建模方法。

Novel rate-area-shape modeling approach to quantify bacterial killing and regrowth for in vitro static time-kill studies.

作者信息

Cheah Soon-Ee, Li Jian, Nation Roger L, Bulitta Jürgen B

机构信息

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Parkville, Victoria, Australia.

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Parkville, Victoria, Australia

出版信息

Antimicrob Agents Chemother. 2015 Jan;59(1):381-8. doi: 10.1128/AAC.04182-14. Epub 2014 Nov 3.

Abstract

In vitro static concentration time-kill (SCTK) studies are a cornerstone for antibiotic development and designing dosage regimens. However, mathematical approaches to efficiently model SCTK curves are scarce. The currently used model-free, descriptive metrics include the log10 change in CFU from 0 h to a defined time and the area under the viable count versus time curve. These metrics have significant limitations, as they do not characterize the rates of bacterial killing and regrowth and lack sensitivity. Our aims were to develop a novel rate-area-shape modeling approach and to compare, against model-free metrics, its relative ability to characterize the rate, extent, and timing of bacterial killing and regrowth from SCTK studies. The rate-area-shape model and the model-free metrics were applied to data for colistin and doripenem against six Acinetobacter baumannii strains. Both approaches identified exposure-response relationships from 0.5- to 64-fold the MIC. The model-based approach estimated an at least 10-fold faster killing by colistin than by doripenem at all multiples of the MIC. However, bacterial regrowth was more extensive (by 2 log10) and occurred approximately 3 h earlier for colistin than for doripenem. The model-free metrics could not consistently differentiate the rate and extent of killing between colistin and doripenem. The time to 2 log10 killing was substantially faster for colistin. The rate-area-shape model was successfully implemented in Excel. This new model provides an improved framework to distinguish between antibiotics with different rates of bacterial killing and regrowth and will enable researchers to better characterize SCTK experiments and design subsequent dynamic studies.

摘要

体外静态浓度时间杀菌(SCTK)研究是抗生素研发和制定给药方案的基石。然而,有效模拟SCTK曲线的数学方法却很匮乏。目前使用的无模型描述性指标包括从0小时到特定时间CFU的log10变化以及活菌数与时间曲线下的面积。这些指标存在显著局限性,因为它们无法描述细菌杀灭和再生长的速率,且缺乏敏感性。我们的目标是开发一种新的速率-面积-形状建模方法,并与无模型指标比较,以评估其在表征SCTK研究中细菌杀灭和再生长的速率、程度及时间方面的相对能力。将速率-面积-形状模型和无模型指标应用于黏菌素和多黏菌素对六种鲍曼不动杆菌菌株的数据。两种方法均确定了在0.5至64倍MIC范围内的暴露-反应关系。基于模型的方法估计,在所有MIC倍数下,黏菌素的杀菌速度至少比多黏菌素快10倍。然而,黏菌素的细菌再生长更为广泛(相差2个log10),且比多黏菌素早约3小时出现。无模型指标无法始终区分黏菌素和多黏菌素之间的杀灭速率和程度。黏菌素达到2个log10杀灭所需的时间明显更短。速率-面积-形状模型已成功在Excel中实现。这个新模型为区分具有不同细菌杀灭和再生长速率的抗生素提供了一个改进的框架,将使研究人员能够更好地表征SCTK实验并设计后续的动态研究。

相似文献

1
Novel rate-area-shape modeling approach to quantify bacterial killing and regrowth for in vitro static time-kill studies.
Antimicrob Agents Chemother. 2015 Jan;59(1):381-8. doi: 10.1128/AAC.04182-14. Epub 2014 Nov 3.
2
Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.
Antimicrob Agents Chemother. 2015 Apr;59(4):2286-98. doi: 10.1128/AAC.04379-14. Epub 2015 Feb 2.
3
In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.
Antimicrob Agents Chemother. 2015 Dec;59(12):7316-9. doi: 10.1128/AAC.00493-15. Epub 2015 Sep 14.
6
In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem.
Antimicrob Agents Chemother. 2014;58(2):1195-9. doi: 10.1128/AAC.01779-13. Epub 2013 Nov 18.
9
Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance.
Antimicrob Agents Chemother. 2016 Jun 20;60(7):3921-33. doi: 10.1128/AAC.02927-15. Print 2016 Jul.
10
In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii.
Diagn Microbiol Infect Dis. 2007 Apr;57(4):419-22. doi: 10.1016/j.diagmicrobio.2006.10.006. Epub 2006 Dec 22.

引用本文的文献

2
Spatial constraints and stochastic seeding subvert microbial arms race.
PLoS Comput Biol. 2024 Jan 26;20(1):e1011807. doi: 10.1371/journal.pcbi.1011807. eCollection 2024 Jan.
3
Generating Robust and Informative Nonclinical and Bacterial Infection Model Efficacy Data To Support Translation to Humans.
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02307-18. Print 2019 May.
4
Antibacterial activity and mode of action of totarol against in carrot juice.
J Food Sci Technol. 2018 Mar;55(3):924-934. doi: 10.1007/s13197-017-3000-2. Epub 2018 Feb 3.
5
Antimicrobial, antioxidant, and antitumor activity of epsilon-poly-L-lysine and citral, alone or in combination.
Food Nutr Res. 2016 Jun 15;60:31891. doi: 10.3402/fnr.v60.31891. eCollection 2016.
6
Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
J Antibiot (Tokyo). 2016 Jun;69(6):415-21. doi: 10.1038/ja.2015.127. Epub 2015 Dec 16.
7
Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.
J Antimicrob Chemother. 2015 Sep;70(9):2589-97. doi: 10.1093/jac/dkv135. Epub 2015 May 28.

本文引用的文献

1
Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs.
Pharmacol Rev. 2013 Jun 26;65(3):1053-90. doi: 10.1124/pr.111.005769. Print 2013 Jul.
2
The future of antibiotics and resistance.
N Engl J Med. 2013 Jan 24;368(4):299-302. doi: 10.1056/NEJMp1215093.
3
In vitro pharmacodynamics of AZD5206 against Staphylococcus aureus.
Antimicrob Agents Chemother. 2013 Feb;57(2):1062-4. doi: 10.1128/AAC.01208-12. Epub 2012 Dec 10.
4
Activity of telavancin compared to other agents against coagulase-negative staphylococci with different resistotypes by time kill.
Diagn Microbiol Infect Dis. 2012 Jul;73(3):287-9. doi: 10.1016/j.diagmicrobio.2012.04.003. Epub 2012 May 8.
5
Bactericidal activity of multiple combinations of tigecycline and colistin against NDM-1-producing Enterobacteriaceae.
Antimicrob Agents Chemother. 2012 Jun;56(6):3441-3. doi: 10.1128/AAC.05682-11. Epub 2012 Mar 5.
7
In vitro time-kill analysis of oritavancin against clinical isolates of methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin.
Diagn Microbiol Infect Dis. 2011 Dec;71(4):470-3. doi: 10.1016/j.diagmicrobio.2011.09.002. Epub 2011 Oct 21.
8
Optimizing dosage to prevent emergence of resistance - lessons from in vitro models.
Curr Opin Pharmacol. 2011 Oct;11(5):453-6. doi: 10.1016/j.coph.2011.07.009. Epub 2011 Aug 23.
9
Dosing of colistin-back to basic PK/PD.
Curr Opin Pharmacol. 2011 Oct;11(5):464-9. doi: 10.1016/j.coph.2011.07.004. Epub 2011 Aug 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验